Perrigo to buy assets of Sergeant's Pet Care for $285 mln

By Admin
Share
Perrigo Company has signed a deal to buy all the assets of Sergeants Pet Care Products, Inc for $285 million in cash. Pet Care is a Nebraska-based manu...

Perrigo Company has signed a deal to buy all the assets of Sergeant’s Pet Care Products, Inc for $285 million in cash. Pet Care is a Nebraska-based manufacturer of OTC companion animal healthcare products.

Perrigo aims to receive larger tax benefit as a result of buying assets of Sergeant. This increase in basis is likely to result in cash tax savings to Perrigo over the next 15 years.  

The net present value of this tax benefit is estimated to be around $50 million. The acquisition is anticipated to close during the company’s fiscal 2013 second quarter.

Perrigo Chairman and CEO Joseph C. Papa said, “This acquisition allows us to penetrate the pet care category by offering numerous flea and tick, health and well-being and consumable products to pet owners at affordable prices.” Mr. Joseph also said, “Sergeant’s has proven record of innovation, high-quality manufacturing with great customer service. We welcome Sergeant’s two hundred-plus employees and over one thousand SKU’s to the Perrigo family.”

The manufacturer and marketer of over-the-counter drugs intends to fund the transaction using cash on hand.

 Perrigo Company is a manufacturer of private label over-the-counter pharmaceuticals in the U.S. It is engaged in manufacturing and sale of consumer healthcare products, generic prescription drugs, active pharmaceutical ingredients and consumer products. 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma